Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fine needle aspiration of renal cortical lesions in adults
    Meeting Abstract

    Iyengar, P.; Al-Ahmadie, H.; Reuter, V. E.; Olgac, S.; Lin, O.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Fine needle aspiration of renal cortical lesions in adults
    Meeting Abstract

    Iyengar, P.; Al-Ahmadie, H.; Reuter, V. E.; Olgac, S.; Lin, O.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AML
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T. A.; Dupont, B.; Petersdorf, E. W.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Lack of HLA-C group 2 KIR ligand in the recipient predictive of lower relapse and higher overall survival in unrelated transplants
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T.; Pinto-Agnello, C.; Dupont, B.; Petersdorf, E.
    Tissue Antigens (2005)

    Fulltext@MSK | Save
  • Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat
    Meeting Abstract

    Horwitz, S.; Moskowitz, C.; Kewalramani, T.; Hamlin, P.; Straus, D.; O'connor, O.; Noy, A.; Portlock, C.; Nimer, S.; Palomba, M. L.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Post-operative radiotherapy in the treatment of paranasal sinus and nasal cavity and cancer
    Meeting Abstract

    Hoppe, B. S.; Lee, N.; Rosenzweig, K.; Wolden, S.; Narayana, A.; Serrano, V.; Wang, J.; Patel, S.; Shah, J.; Kraus, D. H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2005)

    Fulltext@MSK | Save
  • Prognostic significance of residual mass at the end of therapy in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study (IRS). IV experience
    Meeting Abstract

    Hawkins, D. S.; Stoner, J.; Kao, S.; Rodeberg, D.; Hayes-Jordan, A.; Qualman, S.; Wolden, S.; Meyer, W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs
    Meeting Abstract

    Heaney, M. L.; Gardner, J. R.; Karasavvas, N.; Golde, D. W.; Scheinberg, D. A.; Smith, E. A.; O'Connor, O. A.
    Blood (2005)

    Fulltext@MSK | Save
  • The serum free light chain ratio after one or two cycles of treatment is highly predictive of the magnitude of final response in patients undergoing initial treatment for multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Riedel, E. R.; Hedvat, C. V.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL
    Meeting Abstract

    Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; more...
    Blood (2005)

    Fulltext@MSK | Save